文献速递冠心病外科

性别差异与全动脉化冠状动脉旁路移植术远期生存的关系

Sex differences in long-term survival after total arterial coronary artery bypass grafting.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

该回顾性分析基于澳大利亚与新西兰心胸外科数据库并关联国家死亡指数,纳入2001年6月至2020年1月首次单纯冠状动脉旁路移植且至少使用2支移植血管的患者69624例,其中女性13019例(18.7%)。按性别分层倾向性评分匹配后,全动脉化血运重建(TAR)较至少使用1支大隐静脉桥显著降低男性和女性远期全因死亡率,性别交互作用无统计学意义。

要点

  • 匹配后男性14951对、女性3530对,TAR与男性全因死亡风险降低相关(HR 0.86)。
  • TAR与女性全因死亡风险降低相关(HR 0.82)。
  • 性别交互作用分析未见显著亚组效应(P=0.573)。

核心结论

  • 与至少使用1支大隐静脉桥相比,TAR在女性和男性中均提供可比且更优的远期生存结局。

研究设计与样本

  • 回顾性分析澳大利亚与新西兰心胸外科数据库,并与国家死亡指数进行行政关联。
  • 纳入2001年6月至2020年1月期间所有首次单纯冠状动脉旁路移植患者。
  • 在按性别分层后,采用倾向性评分匹配(36个变量)和Cox比例风险回归进行校正比较。
  • 采用Cox交互项分析探讨性别对TAR生存获益的影响。
  • 共纳入69624例接受至少2支移植血管的合格患者,其中女性13019例(18.7%)。

主要发现

  • 匹配后生成男性14951对和女性3530对。
  • 与依赖静脉桥的手术相比,TAR与男性远期全因死亡发生率显著降低相关(HR 0.86;95%CI 0.81-0.91;P<0.001)。
  • 与依赖静脉桥的手术相比,TAR与女性远期全因死亡发生率显著降低相关(HR 0.82;95%CI 0.73-0.91;P<0.001)。
  • 交互项分析表明性别对TAR生存优势无显著亚组效应(P=0.573)。
  • TAR提供的治疗效果在大多数按性别分层的疾病亚组中仍显著。

关键数值与推荐

  • 主要结局为全因死亡率。
  • 男性TAR vs 依赖静脉桥:HR 0.86(95%CI 0.81-0.91;P<0.001)。
  • 女性TAR vs 依赖静脉桥:HR 0.82(95%CI 0.73-0.91;P<0.001)。
  • 性别交互作用P=0.573。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: It is uncertain if the evidence on improved long-term survival of total arterial coronary artery bypass grafting applies to female patients. This study aims to compare the long-term survival outcomes of using total arterial revascularization (TAR) versus at least 1 saphenous vein graft separately for men and women. METHODS: This retrospective analysis of the Australian and New Zealand Society of Cardiac-Thoracic Surgical Database had administrative linkage to the National Death Index. We identified all patients undergoing primary isolated coronary bypass from June 2001 to January 2020 inclusive. Following sex stratification, propensity score matching with 36 variables and Cox proportional hazard regression were used to facilitate adjusted comparisons. A Cox interaction-term analysis was performed to investigate the impact of sex on TAR survival benefit. The primary outcome was all-cause mortality. RESULTS: Of the 69 624 eligible patients receiving at least 2 grafts, 13 019 (18.7%) were female patients. Matching generated 14 951 male and 3530 female pairs. Compared to vein-dependent procedures, TAR was associated with significantly reduced incidence of long-term all-cause mortality for both male (hazard ratio, 0.86; 95% confidence interval, 0.81-0.91; P < 0.001) and female (hazard ratio, 0.82; 95% confidence interval, 0.73-0.91; P < 0.001) cohorts. Interaction-term analysis indicated no significant subgroup effect from sex (P = 0.573) on the survival advantage of TAR. The treatment effect provided by TAR remained significant across most sex-stratified disease subgroups. CONCLUSIONS: TAR, when compared to the use of at least 1 saphenous vein graft, provides comparable superior long-term survival outcomes in both females and males.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Ren J, Bowyer A, Tian DH, et al. Sex differences in long-term survival after total arterial coronary artery bypass grafting. Eur J Cardiothorac Surg. 2024. PMID: 38492562. doi:10.1093/ejcts/ezae106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。